Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin

PLoS Neglected Tropical Diseases
Kossi KomlanPeter T Soboslay

Abstract

Mass drug administration (MDA) of ivermectin has become the main intervention to control onchocerciasis or "river blindness". In Togo, after many years of MDA, Onchocerca volvulus infection has declined dramatically, and elimination appears achievable, but in certain river basins the current situation remains unknown. We have conducted parasitological, serological, ophthalmological, and entomological assessments in northern and central Togo within the river basins of Ôti, Kéran and Mô. Examinations were completed in 1,455 participants from 11 onchocerciasis sentinel villages, and O. volvulus transmission by Simulium damnosum sensu lato (s.l.) was evaluated. In children (aged 1-10 years), the prevalence of microfilariae (Mf) was 2.3% and in adults it ranged from 5.1 to 13.3%. Positive IgG4 responses to O. volvulus adult (crude) worm antigen (OvAg) and the recombinant Ov16 antigen were in all-ages 48.7% and 34.4%, and 29.1% and 14.9% in children, respectively. In the river basin villages of Kéran, Mô and Ôti, the IgG4 seroprevalences to OvAg in children were 51.7%, 23.5% and 12.7%, respectively, and to the Ov16 antigen 33.3% (Kéran) and 5.2% (Ôti). Onchocerciasis ocular lesions (punctate keratitis, evolving iridocyclitis and chor...Continue Reading

Associated Clinical Trials

References

Jun 30, 1990·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R H BakerY Bissan
Sep 28, 2006·PLoS Medicine·María-Gloria BasáñezMichel Boussinesq
Jan 18, 2007·Annals of Tropical Medicine and Parasitology·B Thylefors, M Alleman
Sep 26, 2008·Annals of Tropical Medicine and Parasitology·B Boatin
Sep 26, 2008·Annals of Tropical Medicine and Parasitology·L Yaméogo
Dec 29, 2011·Microbes and Infection·Christian J LechnerPeter T Soboslay
Feb 7, 2014·Parasites & Vectors·Jacinto ConvitMaría E Grillet
Jun 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hugo C TurnerMaría-Gloria Basáñez
Apr 22, 2015·PLoS Neglected Tropical Diseases·Poppy H L LambertonMaría-Gloria Basañez
Jul 15, 2015·PLoS Neglected Tropical Diseases·Mario A Rodríguez-PérezThomas R Unnasch
Jan 16, 2016·PLoS Neglected Tropical Diseases·Simon J O'HanlonMaría-Gloria Basáñez
Jun 15, 2016·Parasites & Vectors·Allison GoldenGonzalo J Domingo
Jan 25, 2017·Expert Review of Anti-infective Therapy·Robert A Cheke

❮ Previous
Next ❯

Citations

Jul 28, 2020·Expert Review of Anti-infective Therapy·Philip MiltonMaría-Gloria Basáñez
Jan 31, 2020·Frontiers in Genetics·Shannon M HedtkeWarwick N Grant

❮ Previous
Next ❯

Datasets Mentioned

BETA
J04659.1

Methods Mentioned

BETA
MDA
enzyme
biopsy
biopsies
ELISA
PCR
ELISAs

Software Mentioned

APOC
ONCHOSIM
Excel
SAS JMP
SDS
EPIONCHO

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.